HNF1A and type 2 diabetes mellitus: This article aims to characterize the differences in results from routine examinations between GCK‐MODY and hepatocyte nuclear factor 1‐α (HNF1A)‐MODY or type 2 diabetes (T2D) patients in different periods of diabetes.